Levofloxacin Istituto Biochimico Italiano G. Lorenzini

Levofloxacin, the active ingredient in Levofloxacin Istituto Biochimico Italiano G. Lorenzini, is a fluoroquinolone antibiotic presented as an injectable solution for intravenous use. It treats susceptible bacterial infections in adult patients. GNH USA supplies Levofloxacin Istituto Biochimico Italiano G. Lorenzini as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat infections caused by susceptible bacteria. - Community‑Acquired Pneumonia: achieves clinical cure and bacterial eradication. - Acute Uncomplicated Urinary Tract Infection: resolves symptoms and clears the pathogen. - Skin and Soft‑Tissue Infections: promotes healing by eliminating causative organisms. - Acute Bacterial Sinusitis: reduces inflammation and clears infection. - Chronic Bronchitis Exacerbation: improves respiratory function and prevents progression.

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema or itching. - Elevated liver enzymes: transient increase in hepatic markers.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Clostridioides difficile infection: colitis due to gut flora disruption. - Peripheral neuropathy: numbness or tingling in extremities. - Seizures: lowered seizure threshold in predisposed patients.

Levofloxacin requires careful assessment of patient risk factors before use. - Renal function: adjust dose in patients with impaired clearance. - Hepatic disease: monitor liver function tests during therapy. - Cardiac risk: avoid in patients with known QT prolongation or arrhythmias. - Concomitant corticosteroids: increase vigilance for tendon injury. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Store at ambient temperature: keep in original container, protect from light and moisture.

Levofloxacin can alter the pharmacokinetics of several drugs, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: markedly reduce levofloxacin absorption. - Warfarin: potentiate anticoagulant effect, increasing bleeding risk. - Cyclosporine: heightened risk of tendon toxicity and nephrotoxicity.

Moderate Interactions (Monitor Closely): - Systemic corticosteroids: monitor for signs of tendon rupture. - Diabetes medications (e.g., insulin, sulfonylureas): may affect glucose control. - Theophylline: levofloxacin can increase serum theophylline concentrations, risking toxicity.